Manfred Raschack

1.2k total citations
40 papers, 999 citations indexed

About

Manfred Raschack is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Manfred Raschack has authored 40 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 16 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Manfred Raschack's work include Nitric Oxide and Endothelin Effects (15 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Renin-Angiotensin System Studies (6 papers). Manfred Raschack is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Renin-Angiotensin System Studies (6 papers). Manfred Raschack collaborates with scholars based in Germany, United States and Hungary. Manfred Raschack's co-authors include Liliane Unger, Berthold Hocher, Christian Bauer, Stephan R. Orth, Eberhard Ritz, Kerstin Amann, Hermann Nawrath, Andreas Lun, Friedrich Priem and Robert Pirker and has published in prestigious journals such as Hypertension, Journal of Medicinal Chemistry and Journal of the American Society of Nephrology.

In The Last Decade

Manfred Raschack

38 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Raschack Germany 21 459 410 268 137 109 40 999
Peter J.S. Chiu United States 17 235 0.5× 174 0.4× 239 0.9× 154 1.1× 60 0.6× 34 776
M. De Luise Australia 14 146 0.3× 192 0.5× 314 1.2× 189 1.4× 145 1.3× 23 895
J. Eileen Bird United States 21 229 0.5× 164 0.4× 305 1.1× 160 1.2× 145 1.3× 38 1.0k
Christopher D. Gove United Kingdom 16 181 0.4× 245 0.6× 360 1.3× 75 0.5× 48 0.4× 40 1.4k
Liangzheng Chang China 9 319 0.7× 460 1.1× 486 1.8× 45 0.3× 40 0.4× 15 1.1k
G. Palladini Italy 20 185 0.4× 159 0.4× 395 1.5× 97 0.7× 54 0.5× 54 1.1k
Akihide Nakao Japan 18 166 0.4× 321 0.8× 345 1.3× 42 0.3× 409 3.8× 36 1.4k
K. K. F. NG Singapore 10 440 1.0× 158 0.4× 504 1.9× 100 0.7× 55 0.5× 20 1.1k
Patrick Vinay Canada 19 220 0.5× 282 0.7× 563 2.1× 63 0.5× 217 2.0× 61 1.2k
Barbara Coles United Kingdom 19 217 0.5× 332 0.8× 590 2.2× 83 0.6× 26 0.2× 33 1.5k

Countries citing papers authored by Manfred Raschack

Since Specialization
Citations

This map shows the geographic impact of Manfred Raschack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Raschack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Raschack more than expected).

Fields of papers citing papers by Manfred Raschack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Raschack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Raschack. The network helps show where Manfred Raschack may publish in the future.

Co-authorship network of co-authors of Manfred Raschack

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Raschack. A scholar is included among the top collaborators of Manfred Raschack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Raschack. Manfred Raschack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Orth, Stephan R., Kerstin Amann, Liliane Unger, et al.. (2000). Adult Human Mesangial Cells (HMCs) Express Endothelin-B-Receptors which Mediate Endothelin-1-Induced Cell Growth. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S232–S237. 22 indexed citations
3.
Kiss, Orsolya, Béla Merkely, Tamás Szabó, et al.. (2000). Endothelin-A-Receptor Antagonist LU 135.252 Inhibits the Formation of Ventricular Arrhythmias Caused By Intrapericardial Infusion of Endothelin-1. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S317–S319. 5 indexed citations
5.
Merkely, Béla, et al.. (2000). The Selective Endothelin-A-Receptor Antagonist LU 135.252 Inhibits the Direct Arrhythmogenic Action of Endothelin-1. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S314–S316. 10 indexed citations
6.
Krajewska, Magdalena, Manfred Raschack, H Herbst, et al.. (2000). Lack of an antifibrotic effect of the mixed endothelin A/B receptorantagonist LU 420627 on rat secondary biliary fibrosis in rats. Journal of Hepatology. 32. 41–41. 4 indexed citations
7.
Orth, Stephan R., et al.. (1999). The ETA Receptor Blocker LU 135252 Prevents Chronic Transplant Nephropathy in the “Fisher to Lewis” Model. Journal of the American Society of Nephrology. 10(2). 387–391. 52 indexed citations
8.
Hocher, Berthold, Andreas Lun, Friedrich Priem, Hans‐H. Neumayer, & Manfred Raschack. (1998). Renal Endothelin System in Diabetes: Comparison of Angiotensin-Converting Enzyme Inhibition and Endothelin-A Antagonism. Journal of Cardiovascular Pharmacology. 31. S492–S495. 31 indexed citations
9.
Raschack, Manfred, et al.. (1998). LU 302 872 and Its Racemate (LU 224 332) Show Balanced Endothelin-A/B Receptor Affinity, High Oral Activity, and Inhibit Human Prostate Tissue Contractions. Journal of Cardiovascular Pharmacology. 31. S241–S244. 24 indexed citations
10.
Toffoli, Giuseppe, et al.. (1995). Structure-activity relationship of verapamil analogs and reversal of multidrug resistance. Biochemical Pharmacology. 50(8). 1245–1255. 54 indexed citations
11.
Raschack, Manfred, et al.. (1995). Receptor Selectivity of Endothelin Antagonists and Prevention of Vasoconstriction and Endothelin-Induced Sudden Death. Journal of Cardiovascular Pharmacology. 26. S397–399. 31 indexed citations
12.
Raschack, Manfred, et al.. (1995). Receptor Selectivity of Endothelin Antagonists and Prevention of Vasoconstriction and Endothelin-Induced Sudden Death. Journal of Cardiovascular Pharmacology. 26. S397–399. 31 indexed citations
13.
Elger, Bernd, et al.. (1994). Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging. European Journal of Pharmacology. 254(1-2). 65–71. 10 indexed citations
14.
Pirker, Robert, et al.. (1990). Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil. International Journal of Cancer. 45(5). 916–919. 57 indexed citations
15.
Kirchengast, Michael & Manfred Raschack. (1989). Effects of gallopamil, diltiazem and nifedipine on the loss of K+ from ischaemic pig hearts. European Journal of Pharmacology. 160(3). 349–358. 3 indexed citations
16.
Nawrath, Hermann & Manfred Raschack. (1987). Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 1090–1097. 23 indexed citations
17.
Raschack, Manfred, et al.. (1984). Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.. PubMed. 34(11). 1489–97. 54 indexed citations
18.
Nawrath, Hermann & Manfred Raschack. (1984). Calcium antagonistic effects of the radioligand (−)-desmethoxy-verapamil on cardiac and vascular smooth muscle preparations. Cell Calcium. 5(3). 316–316. 8 indexed citations
19.
Raschack, Manfred. (1976). Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil. Naunyn-Schmiedeberg s Archives of Pharmacology. 294(3). 285–291. 39 indexed citations
20.
Raschack, Manfred. (1975). Effects of ajmaline and N-propylajmaline on maximum follow frequency and contractility of the dog heart: short communication.. PubMed. 25(6). 896–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026